<DOC>
	<DOCNO>NCT02520726</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled study determine whether administration sertraline patient exhibit acute stress disorder secondary severe burn contribute prevention post-traumatic stress disorder ( PTSD ) .</brief_summary>
	<brief_title>PTSD Prevention Study Examining Efficacy Sertraline Burn Victims</brief_title>
	<detailed_description />
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Victim traumatic event lead personal injury Patient experience feel intense fear , hopelessness , horror course event immediately afterward Positive screen ASDS ( inclusion randomization phase ) ; total ASDS score ≥ 37 ( include dissociative score ≥ 9 ) count positive screen . Age &lt; 18 Pregnant woman , lactate woman , woman use acceptable form birth control Epilepsy head trauma result seizure Current historical schizophrenia , bipolar disorder , mental retardation , OCD , eat disorder , dementia , delirium , selfinjurious behavior Current/previously diagnose PTSD History hypersensitivity sertraline Trauma occur &gt; 7 day prior likely first treatment randomization phase trial . Unable provide inform consent participation study protocol . Patient high risk recurrent bleed despite surgical stabilization Patient history serotonin syndrome Patient nonfluent English Patient currently prescribe antidepressant ( SSRI , SNRI , TCA , MAOI , mirtazapine , trazodone excess 100mg per day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Posttraumatic stress disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>Sertraline</keyword>
	<keyword>Burns</keyword>
</DOC>